Medically reviewed by Marla Anderson, MD Multiple myeloma is a rare blood cancer that develops in the plasma cells, which are ...

New cell therapy, Cilta-cel, shows promise in the treatment of multiple myeloma, providing a personalised approach with the ...

The panelist discusses how for managing patients with R/R multiple myeloma, community clinicians should focus on personalized ...

1 Multiple myeloma originates in blood plasma cells ... for delivering more individualised treatment options across all stages of disease and could shorten treatment duration.

But after a seemingly random finger fracture, his doctor tested him for elevated protein levels in his blood and told him he had a form of cancer called multiple myeloma. It was sort of an out-of ...

Treating late stage myeloma has multiple challenges. First of all, patients are usually more refractory to the most commonly used agents. And we know from old cohorts that if we see patients ...

In this video interview, Michael Andreini, president and CEO of the Multiple Myeloma Research Foundation (MMRF), discusses ...

Bristol-Myers Squibb is on course to move its BCMA-targeting CAR-T therapy further up the treatment pathway in multiple myeloma ... available to earlier-stage myeloma patients.